Chemotherapy of malignant fibrous histiocytoma.A southwest oncology group report
- 1 November 1977
- Vol. 40 (5) , 2010-2014
- https://doi.org/10.1002/1097-0142(197711)40:5<2010::aid-cncr2820400504>3.0.co;2-1
Abstract
Malignant fibrous histiocytoma is a rare tumor, which constitutes 3-4% of the soft tissue sarcomas. It occurs with maximum frequency in the sixth and seventh decades of life and has a distinct male preponderance. In two-thirds of the patients an extremity is the primary site and approximately one-half develop local recurrences and one-half, distant metastases. Response to combination chemotherapy occurred in 33%, a rate similar to that seen in other sarcomas.This publication has 9 references indexed in Scilit:
- Inflammatory fibrous histiocytoma—An aggressive and lethal lesionCancer, 1976
- Primary malignant fibrous histiocytoma of boneCancer, 1975
- Malignant soft tissue tumors of probable histiocytic origin (malignant fibrous histiocytomas): General considerations and electron microscopic and tissue culture studiesCancer, 1975
- Malignant fibrous histiocytoma with widespread metastases.Autopsy studyCancer, 1974
- Atypical fibrous histiocytoma, malignant fibrous histiocytoma, malignant histiocytoma, and epithelioid sarcoma.A comparative study of 65 tumorsCancer, 1972
- Fibroxanthosarcoma of the soft tissues.A type of malignant fibrous histiocytomaCancer, 1972
- Metastasizing retroperitoneal fibroxanthoma (malignant fibroxanthoma)Cancer, 1970
- Malignant fibrous xanthomasCancer, 1964
- Maximum utilization of the life table method in analyzing survivalJournal of Chronic Diseases, 1958